Daunorubicin hydrochloride
CAS No. 23541-50-6
Daunorubicin hydrochloride ( RP 13057 Hydrochloride;Daunomycin;RP13057 Hydrochloride )
Catalog No. M13676 CAS No. 23541-50-6
Daunorubicin is potent topoisomerase II (Topo II) inhibitor, interacts with DNA by intercalation and inhibition of macromolecular biosynthesis in cancer cells.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 28 | In Stock |
|
10MG | 46 | In Stock |
|
25MG | 76 | In Stock |
|
50MG | 110 | In Stock |
|
100MG | 177 | In Stock |
|
200MG | 282 | In Stock |
|
500MG | 443 | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameDaunorubicin hydrochloride
-
NoteResearch use only, not for human use.
-
Brief DescriptionDaunorubicin is potent topoisomerase II (Topo II) inhibitor, interacts with DNA by intercalation and inhibition of macromolecular biosynthesis in cancer cells.
-
DescriptionDaunorubicin is potent topoisomerase II (Topo II) inhibitor, interacts with DNA by intercalation and inhibition of macromolecular biosynthesis in cancer cells; Daunorubicin is a chemotherapy agent used to treat multiple cancer, secifically used for acute myeloid leukemia (AML), acute lymphocytic leukemia (ALL), chronic myelogenous leukemia (CML), and Kaposi's sarcoma; Daunorubicin and it's derivatives are widely used as payloads in antibody-drug conjugates (ADCs).Chemotherapeutic Agents Approved
-
SynonymsRP 13057 Hydrochloride;Daunomycin;RP13057 Hydrochloride
-
PathwayAntibody Drug Conjugates (ADC)
-
TargetADC Cytotoxin
-
RecptorDNAsynthesis
-
Research AreaCancer
-
IndicationChemotherapeutic
Chemical Information
-
CAS Number23541-50-6
-
Formula Weight563.98
-
Molecular FormulaC27H30ClNO10
-
Purity>98% (HPLC)
-
SolubilityH2O: ≥ 34 mg/mL
-
SMILESC[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C(C4=C(C(=C23)O)C(=O)C5=C(C4=O)C=CC=C5OC)O)(C(=O)C)O)N)O.Cl
-
Chemical Name5,12-Naphthacenedione, 8-acetyl-10-[(3-amino-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-, hydrochloride (1:1), (8S,10S)-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Latif ZA, et al. Cancer. 1980 Mar 15;45(6):1326-33.
2. Hurwitz E, et al. Int J Cancer. 1979 Oct 15;24(4):461-70.
3. Aboud-Pirak E, et al. Proc Natl Acad Sci U S A. 1989 May;86(10):3778-81.
2. Hurwitz E, et al. Int J Cancer. 1979 Oct 15;24(4):461-70.
3. Aboud-Pirak E, et al. Proc Natl Acad Sci U S A. 1989 May;86(10):3778-81.
molnova catalog
related products
-
D211
A novel potent DNA-intercalating payload dimer (PBD dimer) payload for antibody-drug conjugates (ADCs); displays picomolar potency against AML cancer cell lines.
-
MMAD hydrochloride
A potent tubulin inhibitor that is a toxin payload in antibody drug conjugates (ADCs).
-
Mertansine
Mertansine (DM1) is a tubulin inhibitor; thiol-containing maytansinoid that create an antibody-drug conjugate (ADC); an ADC payload.